First Horizon Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.9K | Sell |
|
|||||
|
2025
Q1 | $70.7K | Buy |
|
|||||
|
2024
Q4 | $80.3K | Buy |
|
|||||
|
2024
Q3 | $71.8K | Sell |
|
|||||
|
2024
Q2 | $84.9K | Buy |
|
|||||
|
2024
Q1 | $97.9K | Buy |
|
|||||
|
2023
Q4 | $89.4K | Sell |
|
|||||
|
2023
Q3 | $70.6K | Sell |
|
|||||
|
2023
Q2 | $118K | Sell |
|
|||||
|
2023
Q1 | $121K | Buy |
|
|||||
|
2022
Q4 | $87.7K | Sell |
|
|||||
|
2022
Q3 | $159K | Sell |
|
|||||
|
2022
Q2 | $181K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $74K | Buy |
|
|||||
|
2021
Q3 | $89K | Buy |
|
|||||
|
2021
Q2 | $93K | Buy |
|
|||||
|
2021
Q1 | $51K | Buy |
|